$XERI
XERIANT, INC. Stock $xeri

$xeri Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000147793222008809 Filed on November 21, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$551.9K	$1.369M	$1.800M
YoY Change	-69.33%	256.79%	4903.05%
% of Gross Profit
Research & Development	$0.00	$59.78K	$2.341M
YoY Change	-100.0%	-83.98%
% of Gross Profit
Depreciation & Amortization	$340.00	$15.25K
YoY Change
% of Gross Profit
Operating Expenses	$736.0K	$1.429M	$4.252M
YoY Change	-82.69%	88.81%	4468.83%
Operating Profit	-$736.0K		-$4.252M
YoY Change	-82.69%		4468.83%
Interest Expense	$0.00	-$1.674M	$2.389K
YoY Change	-100.0%	1742.54%	119.78%
% of Operating Profit
Other Income/Expense, Net	-$4.082M		-$195.7K
YoY Change	1985.59%		-16.37%
Pretax Income	-$4.818M	-$3.103M	-$4.448M
YoY Change	8.31%	266.05%	1259.93%
Income Tax
% Of Pretax Income
Net Earnings	-$4.818M	-$3.745M	-$4.448M
YoY Change	8.31%	493.38%	1259.92%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01		-$0.02
Diluted Earnings Per Share	-$0.01	-$10.36K	-$14.50K
COMMON SHARES
Basic Shares Outstanding	361.6M shares	365.2M shares	225.5M shares
Diluted Shares Outstanding	361.6M shares		225.5M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$605.1K	$1.124M	$281.9K
YoY Change	114.67%	16.73%	570.11%
Cash & Equivalents	$498.0K	$1.066M	$281.8K
Short-Term Investments	$107.0K	$57.68K
Other Short-Term Assets	$20.78K	$13.30K	$48.64K
YoY Change	-57.28%	-3.48%	265.17%
Inventory
Prepaid Expenses	$8.231K	$756.00
Receivables
Other Receivables
Total Short-Term Assets	$625.8K	$1.137M	$330.5K
YoY Change	89.37%	16.45%	496.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.641K	$4.409K	$159.4K
YoY Change	-95.83%	-97.39%	-19.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$60.00K
YoY Change
Other Assets		$10.00K
YoY Change
Total Long-Term Assets	$124.1K	$132.8K	$159.4K
YoY Change	-22.15%	-21.55%	-19.19%
TOTAL ASSETS
Total Short-Term Assets	$625.8K	$1.137M	$330.5K
Total Long-Term Assets	$124.1K	$132.8K	$159.4K
Total Assets	$749.9K	$1.270M	$489.9K
YoY Change	53.08%	10.84%	93.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$69.70K	$56.84K	$26.18K
YoY Change	166.23%	-22.37%	-2.35%
Accrued Expenses	$82.65K	$70.96K	$27.50K
YoY Change	200.55%	183.84%	-45.35%
Deferred Revenue
YoY Change
Short-Term Debt	$5.950M	$3.936M	$139.7K
YoY Change	4160.04%	2388.11%	380.79%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.178M	$4.139M	$237.5K
YoY Change	2500.93%	1284.05%	123.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$79.02K	$92.20K	$129.7K
YoY Change	-39.06%	-34.68%	-25.4%
Total Long-Term Liabilities	$79.02K	$92.20K	$129.7K
YoY Change	-39.06%	-34.68%	-25.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.178M	$4.139M	$237.5K
Total Long-Term Liabilities	$79.02K	$92.20K	$129.7K
Total Liabilities	$6.257M	$4.231M	$367.2K
YoY Change	1603.95%	861.19%	31.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.38M	-$16.57M
YoY Change		406.74%
Common Stock	$3.657K	$3.637K	$3.221K
YoY Change	13.54%	24.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.702M	-$164.1K	$122.7K
YoY Change
Total Liabilities & Shareholders Equity	$749.9K	$1.270M	$489.9K
YoY Change	53.08%	10.84%	93.92%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q3
OPERATING ACTIVITIES
Net Income	-$4.818M	-$3.745M	-$4.448M
YoY Change	8.31%	493.38%	1259.92%
Depreciation, Depletion And Amortization	$340.00	$15.25K
YoY Change
Cash From Operating Activities	-$565.3K	-$512.2K	-$2.728M
YoY Change	-79.27%	-20.22%	3482.77%
INVESTING ACTIVITIES
Capital Expenditures	$2.567K	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$115.4K
YoY Change
Cash From Investing Activities	-$2.567K	-$115.4K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$1.669M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	0.000	$2.047M
YoY Change	-100.0%	-100.0%	2481.45%
NET CHANGE
Cash From Operating Activities	-$565.3K	-512.2K	-$2.728M
Cash From Investing Activities	-$2.567K	-115.4K	$0.00
Cash From Financing Activities	$0.00	0.000	$2.047M
Net Change In Cash	-$567.9K	-627.5K	-$680.7K
YoY Change	-16.56%	15.35%	-21605.59%
FREE CASH FLOW
Cash From Operating Activities	-$565.3K	-$512.2K	-$2.728M
Capital Expenditures	$2.567K	$0.00	$0.00
Free Cash Flow	-$567.9K	-$512.2K	-$2.728M
YoY Change	-79.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	5590000	usd
CY2022Q2	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	3936185	usd
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001481504
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	365696144	shares
CY2022Q3	xeri	Dilutive Common Stock Equivalents DilutiveCommonStockEquivalents	0	shares
CY2021Q3	xeri	Dilutive Common Stock Equivalents DilutiveCommonStockEquivalents	0	shares
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	000-54277
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	XERIANT, INC.
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1519178
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	Innovation Centre #1
CY2022Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	3998 FAU Boulevard, Suite 309
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
CY2022Q3	dei	City Area Code CityAreaCode	561
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	491-9595
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	376933144	shares
CY2022Q3	us-gaap	Cash Cash	498039	usd
CY2022Q2	us-gaap	Cash Cash	1065945	usd
CY2022Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	75200	shares
CY2022Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	75200	shares
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	365696144	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3657	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	90060	usd
CY2022Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	94000	usd
CY2021Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	82500	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2340575	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6356	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	598595	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	735985	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	4252213	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-735985	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4252213	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	461842	usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	149028	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	0	usd
CY2021Q3	us-gaap	Legal Fees LegalFees	43750	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	0	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	2389	usd
CY2022Q3	xeri	Loss From Ebenberg Jv LossFromEbenbergJv	-49328	usd
CY2021Q3	xeri	Loss From Ebenberg Jv LossFromEbenbergJv	0	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3570366	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-535	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4081536	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-195702	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4817521	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4447915	usd
CY2022Q3	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-7425	usd
CY2021Q3	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-1177816	usd
CY2022Q3	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-4810096	usd
CY2021Q3	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-3270099	usd
CY2022Q3	xeri	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.01
CY2021Q3	xeri	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.01
CY2022Q3	xeri	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	361552863	shares
CY2021Q3	xeri	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	225497197	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2961705	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	48000	usd
CY2022Q3	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2022Q3	xeri	Fair Value Of Warrants Associated With Convertible Debt FairValueOfWarrantsAssociatedWithConvertibleDebt	1918393	usd
CY2022Q3	xeri	Adjustment For Rounding AdjustmentForRounding	0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	306170	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4817521	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5506663	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	705306	usd
CY2021Q3	xeri	Issuance Of Common Stock Committed In Prior Period Amount IssuanceOfCommonStockCommittedInPriorPeriodAmount	0	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1668500	usd
CY2021Q3	xeri	Shares Issued As Equity Kicker Amount SharesIssuedAsEquityKickerAmount	43753	usd
CY2021Q3	xeri	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	128550	usd
CY2021Q3	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2021Q3	xeri	Conversion Of Convertible Notes And Accrued Interest Amount ConversionOfConvertibleNotesAndAccruedInterestAmount	173070	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	541100	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1060324	usd
CY2021Q3	xeri	Fair Value Of Beneficial Conversion Feature Associated With Convertible Debt FairValueOfBeneficialConversionFeatureAssociatedWithConvertibleDebt	250000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4447915	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	122688	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4817521	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4447915	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	335	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	306170	usd
CY2021Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1060324	usd
CY2022Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	48000	usd
CY2021Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	494700	usd
CY2022Q3	xeri	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	-3470366	usd
CY2021Q3	xeri	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	-535	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	49328	usd
CY2021Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	461842	usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	149028	usd
CY2022Q3	xeri	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	10905	usd
CY2021Q3	xeri	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	245	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-11493	usd
CY2021Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7476	usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	34850	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12861	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50191	usd
CY2022Q3	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10000	usd
CY2021Q3	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-565339	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2727742	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2567	usd
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2567	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1668500	usd
CY2022Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	128549	usd
CY2022Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	250000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2047049	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-567906	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-680693	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1065945	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	962540	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	498039	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	281847	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
CY2021Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	187246	usd
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	117893	usd
CY2022Q3	xeri	Beneficial Conversion Feature Arising From Convertible Notes Payable BeneficialConversionFeatureArisingFromConvertibleNotesPayable	0	usd
CY2021Q3	xeri	Beneficial Conversion Feature Arising From Convertible Notes Payable BeneficialConversionFeatureArisingFromConvertibleNotesPayable	171597	usd
CY2022Q3	xeri	Warrants Issued With Convertible Notes Payable Extinguishment WarrantsIssuedWithConvertibleNotesPayableExtinguishment	1918393	usd
CY2021Q3	xeri	Warrants Issued With Convertible Notes Payable Extinguishment WarrantsIssuedWithConvertibleNotesPayableExtinguishment	0	usd
CY2022Q3	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	243598	usd
CY2022	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	811429	usd
CY2022Q3	xeri	Reacquisition Price Of Modified Convertible Debt Instrument ReacquisitionPriceOfModifiedConvertibleDebtInstrument	5950000	usd
CY2022Q3	xeri	Reacquisition Price Of Fair Value Of Warrants ReacquisitionPriceOfFairValueOfWarrants	1918393	usd
CY2022Q3	xeri	Reacquisition Price Of Cash Payment ReacquisitionPriceOfCashPayment	100000	usd
CY2022Q3	xeri	Original Convertible Debt Instrument Carrying Value OriginalConvertibleDebtInstrumentCarryingValue	6050000	usd
CY2022Q3	xeri	Debt Discount Warrant Carrying Value DebtDiscountWarrantCarryingValue	707585	usd
CY2022Q3	xeri	Original Issue Discount Carrying Value OriginalIssueDiscountCarryingValue	341692	usd
CY2022Q3	xeri	Debt Discount Bcf Carrying Value DebtDiscountBcfCarryingValue	602696	usd
CY2022Q3	xeri	Carrying Value Of Original Debt CarryingValueOfOriginalDebt	4398027	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3570366	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	461482	usd
CY2022Q3	xeri	Carrying Value Of Auctus Note CarryingValueOfAuctusNote	5950000	usd
CY2022Q2	xeri	Carrying Value Of Auctus Note CarryingValueOfAuctusNote	3936185	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	365696144	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	364239001	shares
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	4685615	shares
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	761954	usd
CY2022	xeri	Share Sold During Period ShareSoldDuringPeriod	39366666	shares
CY2022	xeri	Share Sold During Period Value ShareSoldDuringPeriodValue	2078500	usd
CY2022	xeri	Share Issued For Exchange Conversion ShareIssuedForExchangeConversion	7138000	shares
CY2022	xeri	Conversion Of Series A Preferred To Common Stocks Shares ConversionOfSeriesAPreferredToCommonStocksShares	7138	shares
CY2022	xeri	Common Stock Issued For Prior Period Conversions Principal And Interest CommonStockIssuedForPriorPeriodConversionsPrincipalAndInterest	10598544	shares
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	167550	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	4985	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	535	usd
CY2022	xeri	Common Stock Share Issued For Conversion CommonStockShareIssuedForConversion	4229680	shares
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	250000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	3749	usd
CY2022	xeri	Additional Common Shares Issued As Financing Costs AdditionalCommonSharesIssuedAsFinancingCosts	845936	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	134927	usd
CY2022Q3	xeri	Share Issued For Exchange Conversion ShareIssuedForExchangeConversion	1000000	shares
CY2022Q3	xeri	Conversion Of Series A Preferred To Common Stocks Shares ConversionOfSeriesAPreferredToCommonStocksShares	1000	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	457143	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	48000	usd
CY2022Q3	us-gaap	Cash Cash	498039	usd
CY2021Q2	us-gaap	Cash Cash	1065945	usd
CY2022Q3	xeri	Working Capital WorkingCapital	-5551721	usd
CY2021Q2	xeri	Working Capital WorkingCapital	-3002259	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4817521	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4447915	usd
CY2022Q3	xeri	Office Leas OfficeLeas	129667	usd
CY2022Q3	xeri	Operating Lease Liability Current Portion OperatingLeaseLiabilityCurrentPortion	-50647	usd
CY2022Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant assumptions and estimates relate to the valuation of beneficial conversion features and warrants associated with convertible debt. Actual results could differ from these estimates.</p>
CY2022	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	2615419	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79020	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	45589	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2340575	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	15442	usd
CY2021Q3	us-gaap	Advertising Expense AdvertisingExpense	168087	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	62201	usd
CY2022Q3	xeri	Profit Losses ProfitLosses	-4810096	usd
CY2021Q3	xeri	Profit Losses ProfitLosses	-3270099	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	361552863	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	225497197	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	361552863	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	225497197	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	37112	usd
CY2022Q3	xeri	Lease Liabilities Gross LeaseLiabilitiesGross	144901	usd
CY2022Q3	xeri	Present Value Discount PresentValueDiscount	-15235	usd
CY2022Q3	xeri	Operating Lease Liabilities OperatingLeaseLiabilities	129667	usd
CY2022Q3	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.10	pure
CY2022Q3	us-gaap	Prepaid Rent PrepaidRent	4659	usd
CY2022Q3	xeri	Right Of Use Asset Office Lease RightOfUseAssetOfficeLease	220448	usd
CY2022Q3	xeri	Right Of Use Asset Accumulated Amortization RightOfUseAssetAccumulatedAmortization	-103011	usd
CY2022Q3	xeri	Operating Lease Right Of Use Assets1 OperatingLeaseRightOfUseAssets1	117437	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5950000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6050000	usd
CY2022Q3	xeri	Less Unamortized Discount LessUnamortizedDiscount	0	usd
CY2022Q2	xeri	Less Unamortized Discount LessUnamortizedDiscount	-2113815	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5950000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3936185	usd
CY2022Q3	xeri	Schedule Of Loss On Extinguishment On Convertible Debt Instrument ScheduleOfLossOnExtinguishmentOnConvertibleDebtInstrument	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Reacquisition Price:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Modified convertible debt instrument </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,950,000.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value of warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,918,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash payment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Carrying Value of Original Instrument</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Original convertible debt instrument </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,050,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Debt discount - warrant </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(707,585</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Original issue discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(341,692</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Debt discount - BCF </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(602,696</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying value of original debt </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,398,027</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> Loss on extinguishment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,570,366</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>

Files In Submission

Name	View Source	Status
xeri-20220930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
xeri-20220930_def.xml	Edgar Link	unprocessable
xeri-20220930_pre.xml	Edgar Link	unprocessable
0001477932-22-008809-index-headers.html	Edgar Link	pending
0001477932-22-008809-index.html	Edgar Link	pending
0001477932-22-008809.txt	Edgar Link	pending
0001477932-22-008809-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xeri-20220930.xsd	Edgar Link	pending
xeri_10q.htm	Edgar Link	pending
xeri_ex311.htm	Edgar Link	pending
xeri_ex312.htm	Edgar Link	pending
xeri_ex321.htm	Edgar Link	pending
xeri_ex322.htm	Edgar Link	pending
xeri-20220930_cal.xml	Edgar Link	unprocessable
xeri_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XERI
XERIANT, INC. Stock $xeri

2022 Q3 Form 10-Q Financial Statement

#000147793222008809 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XERI XERIANT, INC. Stock $xeri

2022 Q3 Form 10-Q Financial Statement

#000147793222008809 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XERI
XERIANT, INC. Stock $xeri